Skip to main content

Table 2 Forms of Health Service Use Among the Diabetes Cohort by Drug Treatment Categories

From: Barriers to self-monitoring of blood glucose among adults with diabetes in an HMO: A cross sectional study

 

Managed Without Drugs (n = 1,346)

Insulin-Managed (n = 1,428)

Oral Sulfonylurea-Managed (n = 1,791)

Health Service Use Characteristics

Mean Visits

% 1+ Visit

Mean Visits

% 1+ Visit

Mean Visits

% 1+ Visit

Total Health Center Visits*

10.1 ± 8.8

(95.9)

14.2 ± 11.9

(97.5)

10.7 ± 8.5

(97.5)

   Scheduled

8.8 ± 8.1

(94.1)

12.7 ± 10.9

(96.9)

9.6 ± 7.8

(96.5)

   Same Day or Urgent

1.3 ± 1.8

(58.6)

1.6 ± 2.2

(62.0)

1.2 ± 1.7

(56.8)

Specialist Visits (Endocrinology)

0.07 ± 0.46

(3.1)

0.22 ± 0.96

(8.1)

0.05 ± 0.39

(2.7)

Total Emergency Room

0.23 ± 0.63

(16.1)

0.43 ± 1.0

(25.3)

0.26 ± 0.72

(17.0)

Total Hospitalizations

0.17 ± 0.49

(13.1)

0.31 ± 0.77

(20.2)

0.19 ± 0.56

(13.2)

Diabetes Medications

      

   Avg # Dispensing per Yr

---

7.3 ± 3.9

5.5 ± 3.5

   Avg Standard Monthly Dose (SMD)

---

1.3 ± 0.93

1.4 ± 1.3

Self-Monitoring Blood Glucose

      

   Any (1+ Test Strip)

97

(7.2)

936

(65.6)

431

(24.1)

   Regular§

N/A

N/A

320

(22.4)

123

(6.9)

Completed HbA 1c Tests ||

      

Avg # HbA1c Tests per Yr

1.7 ± 0.9

2.2 ± 1.4

2.1 ± 1.3

Total # HbA1c Tests

      

   0

705

(52.4)

317

(22.2)

418

(23.3)

   1

362

(26.9)

430

(30.1)

554

(30.9)

   2

177

(13.2)

315

(22.1)

389

(21.7)

   3+

102

(7.6)

366

(25.6)

430

(24.0)

  1. * Based on AMRS records and includes face-to-face visits. † ER visits include those leading up to a hospitalization. ‡ Based on pharmacy dispensing data. Oral sulfonylurea-managed medication includes acetohexamide, chlorpropamide, glipizide, glyburide, tolazamide, and tolbutamide. §Regular self-monitoring of blood glucose is defined as 90 strips/quarter for those using insulin and 45 strips/quarter for those using oral sulfonylureas. || HbA1c test results reported only for those with at least one test. Managed without drugs n = 641; with insulin = 1,111; with oral sulfonylureas n = 1,373.